Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-011187

EVP, R&D & Chief Scientific Of sold 775 shares at $39.59 ($30,682)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2019-02-15 Sale −775 $39.59 $30,682 271,943 D
Open-market sales · 775 sh · avg $39.59 · $30,682
Loading xslF345X03/doc4.xml…